Since 18 of December 2019 conferences.iaea.org uses Nucleus credentials. Visit our help pages for information on how to Register and Sign-in using Nucleus.

28 October 2019 to 1 November 2019
Vienna International Centre
Europe/Vienna timezone
Announcement and Call for Papers

Clinical indications and labelling procedures influencing in vitro stability and early myocardial uptake of 99mTc-tetrofosmin

29 Oct 2019, 23:44
15m
Vienna International Centre

Vienna International Centre

Wagramerstrasse 5, 1400 Vienna

Speakers

Salah Eddine Bouyoucef (Department of Nuclear Medicine CHU Bab El Oued, 16000 Algiers Algeria)Dr Amel Taïbi (Nuclear medicine department )

Description

99mTc -tetrofosmin is a lipophilic cationic agent (diphosphine group) used for imaging myocardial perfusion at stress and at rest. The myocardial uptake of technetium 99mTc -tetrofosmin appears to occur by a passive diffusion process however, the uptake and retention curve models of technetium 99mTc -tetrofosmin by myocardial tissue are not well established. Particularly early images for myocardial perfusion imaging and stability of 99mTc -tetrofosmin are not well defined. 15 preparations of 99mTc -tetrofosmin and 40 patients have been used to study the different parameters part of the process of labeling in order to study the stability of 99mTc -tetrofosmin and its early uptake at 5 minutes by myocardial muscle. Parameters which have been studied were the PH, temperature of storage, time of agitation and the way of intravenous injection. Radiochromatography was performed at different times during 6 hours and early myocardial uptake was estimated by the ration heart/mediastinum uptake. Early results confirm that constant agitation and storage temperature are influencing the in vitro stability of 99mTc -tetrofosmin meanwhile clinical indications and the PH of the injected solution of 99mTc –tetrofosmin are influencing the early uptake of 99mTc –tetrofosmin by the myocardium.

Primary authors

Salah Eddine Bouyoucef (Department of Nuclear Medicine CHU Bab El Oued, 16000 Algiers Algeria) Mrs Amel Fellah (Nuclear medicine department ) Dr Amel Taïbi (Nuclear medicine department )

Presentation materials

There are no materials yet.